[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR066455A2 - Uso de compuestos n-metil-n-[(1r)-1-fenil-2-(3r)-3-hidroxipirrolidin -1-il-=-etil]-2,2-difenilacetamida para producir un medicamento para el tratamiento de emfermedades intestinales no inflamatorias - Google Patents

Uso de compuestos n-metil-n-[(1r)-1-fenil-2-(3r)-3-hidroxipirrolidin -1-il-=-etil]-2,2-difenilacetamida para producir un medicamento para el tratamiento de emfermedades intestinales no inflamatorias

Info

Publication number
AR066455A2
AR066455A2 ARP080101910A ARP080101910A AR066455A2 AR 066455 A2 AR066455 A2 AR 066455A2 AR P080101910 A ARP080101910 A AR P080101910A AR P080101910 A ARP080101910 A AR P080101910A AR 066455 A2 AR066455 A2 AR 066455A2
Authority
AR
Argentina
Prior art keywords
phenyl
methyl
produce
treatment
hydroxipirrolidin
Prior art date
Application number
ARP080101910A
Other languages
English (en)
Inventor
Karl-August Ackermann
Inge Stein
Rudolf Gottschlich
Bernd Helfert
Andreas Bathe
Jens Budak
Original Assignee
Tioga Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7865063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR066455(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tioga Pharmaceuticals Inc filed Critical Tioga Pharmaceuticals Inc
Publication of AR066455A2 publication Critical patent/AR066455A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B35/00—Reactions without formation or introduction of functional groups containing hetero atoms, involving a change in the type of bonding between two carbon atoms already directly linked
    • C07B35/02—Reduction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00—Formation or introduction of functional groups containing nitrogen
    • C07B43/06—Formation or introduction of functional groups containing nitrogen of amide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Uso de N-metil-N-[(1R)-1-fenil-2-((3R)-3-hidroxipirrolidin-1-il)-etil]-2,2-difenilacetamida o sus sales fisiologicamente aceptable, para producir un medicamento para el tratamiento de enfermedades intestinales no inflamatorias.
ARP080101910A 1998-04-20 2008-05-06 Uso de compuestos n-metil-n-[(1r)-1-fenil-2-(3r)-3-hidroxipirrolidin -1-il-=-etil]-2,2-difenilacetamida para producir un medicamento para el tratamiento de emfermedades intestinales no inflamatorias AR066455A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19817393 1998-04-20
DE19827633A DE19827633A1 (de) 1998-04-20 1998-06-20 Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid

Publications (1)

Publication Number Publication Date
AR066455A2 true AR066455A2 (es) 2009-08-19

Family

ID=7865063

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP990101758A AR019080A1 (es) 1998-04-20 1999-04-16 Procedimiento para preparar a eleccion n-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il)etil]-2,2-difenilaceta-mida o n-metil-n-[(1r)-1-fenil-2-((3r)-3-hidroxipirrolidin-1-il)-etil]-2,2-difenilacetamida.
ARP080101910A AR066455A2 (es) 1998-04-20 2008-05-06 Uso de compuestos n-metil-n-[(1r)-1-fenil-2-(3r)-3-hidroxipirrolidin -1-il-=-etil]-2,2-difenilacetamida para producir un medicamento para el tratamiento de emfermedades intestinales no inflamatorias

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP990101758A AR019080A1 (es) 1998-04-20 1999-04-16 Procedimiento para preparar a eleccion n-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il)etil]-2,2-difenilaceta-mida o n-metil-n-[(1r)-1-fenil-2-((3r)-3-hidroxipirrolidin-1-il)-etil]-2,2-difenilacetamida.

Country Status (28)

Country Link
US (1) US6344566B1 (es)
EP (2) EP1073634B1 (es)
JP (1) JP4688292B2 (es)
KR (1) KR100649175B1 (es)
CN (2) CN1846696A (es)
AR (2) AR019080A1 (es)
AT (2) ATE527999T1 (es)
AU (2) AU761721B2 (es)
BR (1) BR9909731A (es)
CA (1) CA2329210C (es)
CY (1) CY1112314T1 (es)
CZ (1) CZ301121B6 (es)
DE (2) DE19827633A1 (es)
DK (2) DK1073634T3 (es)
ES (2) ES2375384T3 (es)
HK (1) HK1039111A1 (es)
HU (1) HUP0101600A3 (es)
MY (1) MY120471A (es)
NO (1) NO317984B1 (es)
PL (1) PL206969B1 (es)
PT (1) PT1607090E (es)
RU (1) RU2298549C2 (es)
SI (2) SI1073634T1 (es)
SK (2) SK288016B6 (es)
TW (1) TWI249524B (es)
UA (1) UA73472C2 (es)
WO (1) WO1999054298A1 (es)
ZA (1) ZA200006689B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10259245A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
US20080090859A1 (en) * 2003-10-30 2008-04-17 Tioga Pharmaceuticals, Inc. Use of Selective Opiate Receptor Modulators In the Treatment Of Neuropathy
US20070160559A1 (en) * 2006-01-12 2007-07-12 Roszell James A Skin disinfectant composition and methods for using
RU2441655C2 (ru) 2007-03-30 2012-02-10 Тиога Фармасьютикалз Инк. Агонисты каппа-опиоидов для лечения синдрома раздраженного кишечника с преобладанием диареи и перемежающегося синдрома раздраженного кишечника
CN103664727A (zh) * 2013-12-19 2014-03-26 无锡万全医药技术有限公司 一种一锅法制备1-[(3s)-3-羟基吡咯烷-1-基]-(2s)-2-甲氨基-2-苯基乙烷的工艺
CN103772257A (zh) * 2013-12-31 2014-05-07 无锡万全医药技术有限公司 一种制备2-((3s)-3-羟基吡咯烷-1-基)-(1s)-1-苯乙基氨基甲酸酯的方法
EP3277274B1 (en) 2015-04-01 2024-06-12 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
CN112574068A (zh) * 2020-11-17 2021-03-30 万华化学（宁波）有限公司 一种低色号高稳定性碳化二亚胺改性异氰酸酯的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232978A (en) * 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide
DE4425071C2 (de) * 1994-07-15 1996-08-29 Degussa Verfahren zur Herstellung optisch aktiver Pyrrolidine mit hoher Enantiomerenreinheit
DE19523502A1 (de) * 1995-06-28 1997-01-02 Merck Patent Gmbh Kappa-Opiatagonisten für entzündliche Darmerkrankungen
DE19531464A1 (de) * 1995-08-26 1997-02-27 Merck Patent Gmbh N-Methyl-N-[(1S-)-1-phenyl-2-((3S)-3-hydroxypyrrolidin 1-yl-)-ethyl]-2,2-diphenyl-acetamid
US5968968A (en) * 1996-07-24 1999-10-19 Warner-Lambert Company Diphenyl-cyclopropenes as selective K-agonists
DE19647538A1 (de) * 1996-11-16 1998-05-20 Merck Patent Gmbh Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[1-phenyl-2-(-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid

Also Published As

Publication number Publication date
CZ20003860A3 (cs) 2001-01-17
ZA200006689B (en) 2002-02-18
NO317984B1 (no) 2005-01-17
AR019080A1 (es) 2001-12-26
SI1607090T1 (sl) 2012-01-31
EP1073634A1 (de) 2001-02-07
SI1073634T1 (sl) 2006-02-28
DK1607090T3 (da) 2012-01-30
HUP0101600A3 (en) 2002-12-28
ATE303361T1 (de) 2005-09-15
ATE527999T1 (de) 2011-10-15
CN1846696A (zh) 2006-10-18
BR9909731A (pt) 2000-12-19
WO1999054298A1 (de) 1999-10-28
US6344566B1 (en) 2002-02-05
PL343556A1 (en) 2001-08-27
SK15572000A3 (sk) 2001-05-10
CN1310884C (zh) 2007-04-18
MY120471A (en) 2005-10-31
CA2329210A1 (en) 1999-10-28
HK1039111A1 (en) 2002-04-12
AU761721B2 (en) 2003-06-05
PL206969B1 (pl) 2010-10-29
EP1607090A1 (de) 2005-12-21
RU2298549C2 (ru) 2007-05-10
EP1073634B1 (de) 2005-08-31
CY1112314T1 (el) 2015-12-09
PT1607090E (pt) 2012-01-10
JP2002512223A (ja) 2002-04-23
SK288016B6 (sk) 2012-11-05
UA73472C2 (en) 2005-08-15
CA2329210C (en) 2008-03-04
DK1073634T3 (da) 2006-01-09
KR100649175B1 (ko) 2006-11-24
ES2375384T3 (es) 2012-02-29
AU4031199A (en) 1999-11-08
HUP0101600A2 (hu) 2001-09-28
NO20005259L (no) 2000-10-19
AU2003248428B2 (en) 2005-10-20
CZ301121B6 (cs) 2009-11-11
AU2003248428A1 (en) 2003-11-06
NO20005259D0 (no) 2000-10-19
SK286442B6 (sk) 2008-10-07
KR20010042750A (ko) 2001-05-25
JP4688292B2 (ja) 2011-05-25
TWI249524B (en) 2006-02-21
DE59912502D1 (de) 2005-10-06
EP1607090B1 (de) 2011-10-12
ES2251194T3 (es) 2006-04-16
CN1297435A (zh) 2001-05-30
DE19827633A1 (de) 1999-10-21

Similar Documents

Publication Publication Date Title
AR066455A2 (es) Uso de compuestos n-metil-n-[(1r)-1-fenil-2-(3r)-3-hidroxipirrolidin -1-il-=-etil]-2,2-difenilacetamida para producir un medicamento para el tratamiento de emfermedades intestinales no inflamatorias
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
AR029175A1 (es) Derivados 2-amino-fenilpurina, un proceso para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la preparacion de un medicamento
MA26939A1 (fr) Forme posologique de medicament commandee par un hydrogel
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
NO20032233D0 (no) Synergistiske foreninger som innbefatter en renininhibitor for kardiovaskul¶re sykdommer
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
PT1183015E (pt) Pastilha em multicamadas para administracao de uma combinacao fixa de tramadol e diclofenac
HUP0201623A3 (en) Use of (s,s)reboxetine a selective norepinephrine reuptake inhibitor for the preparation of pharmaceutical compositions treating disorders of the nervous system
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
SI0752246T1 (en) Use of N-methyl-N-((1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)-ethyl)-2,2-diphenyl acetamide hydrochloride for the preparation of a medicament for the treatment of inflammatory diseases of the intestine
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
ES2253378T3 (es) Extractos de espermatofitos con actividad antineoplasica.
CL2009000980A1 (es) Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006).
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
AR041865A1 (es) Derivados terapeuticos de prolina y su uso en el tratamiento de epilepsia y dolor
ATE332894T1 (de) Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény

Legal Events

Date Code Title Description
FB Suspension of granting procedure